Free Trial
Final Hours! Save $100 on MarketBeat All Access Before 11:59 PM
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149 Tonight
Claim MarketBeat All Access Sale Promotion
Terence Flynn

Terence Flynn Analyst Performance

Managing Director - Equity Research Pharma & Biotech Analyst at Morgan Stanley

Terence Flynn is a stock analyst at Morgan Stanley in the medical sector, covering 25 publicly traded companies. Over the past year, Terence Flynn has issued 82 stock ratings, including buy, hold, and sell recommendations. While full access to Terence Flynn's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Terence Flynn's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
118 Last 11 Years
Buy Recommendations
51.38% 56 Buy Ratings
Companies Covered
25 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy51.4%56 ratings
Hold45.0%49 ratings
Sell3.7%4 ratings

Out of 109 total stock ratings issued by Terence Flynn at Morgan Stanley, the majority (51.4%) have been Buy recommendations, followed by 45.0% Hold and 3.7% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
60.0% of companies on NASDAQ
15 companies
NYSE
40.0% of companies on NYSE
10 companies

Terence Flynn, an analyst at Morgan Stanley, currently covers 25 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
25 companies
100.0%

Terence Flynn of Morgan Stanley specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
16 companies
64.0%
LARGE CAP PHARMA
5 companies
20.0%
MED - DRUGS
1 company
4.0%
MEDICAL SERVICES
1 company
4.0%
HOSPITAL & MEDICAL SERVICE PLANS
1 company
4.0%
PHARMACEUTICAL PREPARATIONS
1 company
4.0%

Terence Flynn's Ratings History at Morgan Stanley

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Alumis Inc. stock logo
ALMS
Alumis
5/15/2026Reiterated Rating$24.06$39.00Overweight
Biohaven Ltd. stock logo
BHVN
Biohaven
5/13/2026Lower Price Target$8.97$18.00Overweight
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
5/11/2026Boost Price Target$25.61$22.00Equal Weight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
5/7/2026Set Price Target$580.95$516.00
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
5/5/2026Boost Price Target$418.09$616.00Overweight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
5/1/2026Reiterated Rating$961.47$1,344.00Overweight
Amgen Inc. stock logo
AMGN
Amgen
5/1/2026Set Price Target$326.04$332.00
AbbVie Inc. stock logo
ABBV
AbbVie
4/30/2026Boost Price Target$211.67$278.00Overweight
Amgen Inc. stock logo
AMGN
Amgen
4/28/2026Boost Price Target$343.85$326.00Equal Weight
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
4/27/2026Boost Price Target$13.22$15.00Equal Weight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4/15/2026Set Price Target$238.02$283.00
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
4/10/2026Boost Price Target$47.87$63.00Overweight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
4/10/2026Boost Price Target$569.04$519.00Equal Weight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
4/10/2026Boost Price Target$437.02$612.00Overweight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
4/10/2026Boost Price Target$93.13$126.00Overweight
Amgen Inc. stock logo
AMGN
Amgen
4/10/2026Boost Price Target$354.48$326.00Equal Weight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
4/10/2026Boost Price Target$939.18$1,327.00Overweight
Pfizer Inc. stock logo
PFE
Pfizer
4/10/2026Boost Price Target$27.02$28.00Equal Weight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4/10/2026Boost Price Target$239.90$267.00Overweight
Alumis Inc. stock logo
ALMS
Alumis
3/20/2026Boost Price Target$25.38$38.00Overweight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
3/18/2026Set Price Target$237.17$253.00
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
3/18/2026Reiterated Rating$237.60Overweight
Pfizer Inc. stock logo
PFE
Pfizer
3/17/2026Set Price Target$27.10$27.00Positive
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
3/10/2026Lower Price Target$83.60$125.00Overweight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
3/10/2026Boost Price Target$499.41$596.00Overweight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
3/5/2026Reiterated Rating$986.00$1,313.00Overweight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/13/2026Reiterated Rating$495.48$570.00Overweight
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
2/12/2026Reiterated Rating$44.23$61.00Overweight
Biogen Inc. stock logo
BIIB
Biogen
2/8/2026Set Price Target$201.18$190.00
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
2/6/2026Reiterated Rating$61.43$40.00Underweight
AbbVie Inc. stock logo
ABBV
AbbVie
2/5/2026Boost Price Target$217.04$270.00Overweight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2/5/2026Boost Price Target$1,107.13$1,313.00Overweight
Amgen Inc. stock logo
AMGN
Amgen
2/4/2026Boost Price Target$338.59$309.00Equal Weight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
1/28/2026Set Price Target$224.50$262.00Overweight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
1/22/2026Boost Price Target$219.82$200.00Equal Weight
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
1/8/2026Reiterated Rating$23.19$20.00Equal Weight
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
1/8/2026Set Price Target$18.49$36.00Overweight
Alumis Inc. stock logo
ALMS
Alumis
1/7/2026Boost Price Target$16.23$33.00Overweight
Biohaven Ltd. stock logo
BHVN
Biohaven
1/6/2026Lower Price Target$9.47$21.00Overweight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
12/12/2025Boost Price Target$210.42$197.00Equal Weight
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
Pfizer Inc. stock logo
PFE
Pfizer
12/12/2025Lower Price Target$25.90$28.00Equal Weight
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
12/12/2025Reiterated Rating$51.16$37.00Underweight
Structure Therapeutics Inc. Sponsored ADR stock logo
GPCR
Structure Therapeutics
12/12/2025Boost Price Target$66.60$125.00Overweight
Biogen Inc. stock logo
BIIB
Biogen
12/12/2025Boost Price Target$173.12$156.00Equal Weight
Amgen Inc. stock logo
AMGN
Amgen
12/12/2025Lower Price Target$315.74$304.00Equal Weight
AbbVie Inc. stock logo
ABBV
AbbVie
12/12/2025Boost Price Target$222.00$269.00Overweight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
12/12/2025Boost Price Target$99.54$102.00Equal Weight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
12/5/2025Set Price Target$461.18$564.00
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
12/3/2025Upgrade$433.15$516.00Overweight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
12/2/2025Boost Price Target$100.74$120.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
11/24/2025Boost Price Target$1,058.05$1,290.00Overweight
Biohaven Ltd. stock logo
BHVN
Biohaven
11/18/2025Lower Price Target$9.58$26.00Overweight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
11/13/2025Boost Price Target$1,018.28$1,171.00Overweight
Organon & Co. stock logo
OGN
Organon & Co.
11/11/2025Lower Price Target$7.73$9.00Equal Weight
Biohaven Ltd. stock logo
BHVN
Biohaven
11/5/2025Reiterated Rating$8.42Overweight
Amgen Inc. stock logo
AMGN
Amgen
11/5/2025Lower Price Target$296.70$329.00Equal Weight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
11/3/2025Reiterated Rating$103.96$134.00Overweight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
11/3/2025Boost Price Target$83.42$100.00Equal Weight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
10/29/2025Set Price Target$455.43$447.00
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
10/15/2025Set Price Target$190.88$190.00
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
10/14/2025Lower Price Target$9.17$15.00Equal Weight
Pfizer Inc. stock logo
PFE
Pfizer
10/10/2025Lower Price Target$25.08$32.00Equal Weight
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
10/10/2025Lower Price Target$36.06$54.00Overweight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
10/10/2025Lower Price Target$104.48$131.00Overweight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
10/10/2025Boost Price Target$443.68$435.00Equal Weight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
10/10/2025Boost Price Target$191.29$178.00Equal Weight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
10/3/2025Lower Price Target$820.69$1,023.00Overweight
Alumis Inc. stock logo
ALMS
Alumis
8/15/2025Lower Price Target$4.39$22.00Overweight
Biohaven Ltd. stock logo
BHVN
Biohaven
8/12/2025Lower Price Target$13.42$54.00Overweight
Pfizer Inc. stock logo
PFE
Pfizer
8/6/2025Boost Price Target$23.96$33.00Equal Weight
Amgen Inc. stock logo
AMGN
Amgen
8/6/2025Boost Price Target$284.41$333.00Equal Weight
AbbVie Inc. stock logo
ABBV
AbbVie
8/1/2025Boost Price Target$193.55$255.00Overweight
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
7/31/2025Reiterated Rating$43.37Hold
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
7/17/2025Boost Price Target$164.78$176.00Equal Weight
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
7/15/2025Set Price Target$12.69$16.00Equal Weight
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
7/10/2025Boost Price Target$36.18$54.00Overweight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
7/10/2025Boost Price Target$112.29$133.00Overweight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
7/10/2025Reiterated Rating$792.63$1,135.00Overweight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
7/10/2025Lower Price Target$84.40$98.00Equal Weight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
7/10/2025Boost Price Target$157.81$171.00Equal Weight
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
7/10/2025Lower Price Target$48.17$34.00Underweight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
7/10/2025Lower Price Target$301.15$328.00Equal Weight
Arvinas, Inc. stock logo
ARVN
Arvinas
5/9/2025Lower Price Target$6.69$11.00Equal Weight
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
5/9/2025Lower Price Target$8.46$22.00Overweight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
5/6/2025Lower Price Target$99.33$132.00Overweight
Organon & Co. stock logo
OGN
Organon & Co.
5/5/2025Lower Price Target$8.82$10.00Equal Weight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
5/1/2025Boost Price Target$296.52$348.00Equal Weight
AbbVie Inc. stock logo
ABBV
AbbVie
4/28/2025Boost Price Target$185.96$250.00Overweight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4/16/2025Boost Price Target$154.80$169.00Equal Weight
Organon & Co. stock logo
OGN
Organon & Co.
4/9/2025Lower Price Target$11.32$15.00Equal Weight
Your book is inside (Ad)

The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel

Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
4/9/2025Lower Price Target$702.91$1,124.00Overweight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4/9/2025Boost Price Target$146.25$164.00Equal Weight
AbbVie Inc. stock logo
ABBV
AbbVie
4/9/2025Boost Price Target$167.66$241.00Overweight
Amgen Inc. stock logo
AMGN
Amgen
4/9/2025Boost Price Target$272.28$330.00Equal Weight
Arvinas, Inc. stock logo
ARVN
Arvinas
3/13/2025Lower Price Target$8.58$12.00Equal Weight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
3/11/2025Lower Price Target$100.97$139.00Overweight
Biohaven Ltd. stock logo
BHVN
Biohaven
3/7/2025Lower Price Target$30.08$63.00Overweight
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
2/18/2025Lower Price Target$11.00$25.00Overweight
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
2/14/2025Boost Price Target$43.49$32.00Underweight
Organon & Co. stock logo
OGN
Organon & Co.
2/14/2025Lower Price Target$16.17$16.00Equal Weight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2/5/2025Lower Price Target$90.99$106.00Equal Weight
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
2/3/2025Boost Price Target$19.71$17.00Equal Weight
AbbVie Inc. stock logo
ABBV
AbbVie
2/3/2025Boost Price Target$188.39$239.00Overweight
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
1/27/2025Downgrade$10.99$11.00Equal Weight
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
1/23/2025Lower Price Target$146.82$163.00Equal Weight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
1/21/2025Lower Price Target$96.46$113.00Equal Weight